Immunic Inc (IMUX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,945 | -71,760 | -52,468 | -34,534 | -44,017 |
| Depreciation Amortization | 85 | 45 | 29 | 14 | 39 |
| Accounts payable and accrued liabilities | 176 | -261 | 483 | 6,773 | 1,000 |
| Other Working Capital | -9,279 | -4,147 | -3,130 | 8,863 | -2,365 |
| Other Operating Activity | 18,730 | 16,571 | 13,133 | 5,936 | -781 |
| Operating Cash Flow | $-83,233 | $-59,552 | $-41,953 | $-12,948 | $-46,124 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -67 | -48 | -28 | -10 | -146 |
| Investing Cash Flow | $-67 | $-48 | $-28 | $-10 | $-146 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 42,841 | 42,020 | N/A | 0 | 144,431 |
| Financing Cash Flow | $42,841 | $42,020 | $N/A | $0 | $144,431 |
| Exchange Rate Effect | -130 | 572 | 1,704 | 345 | -78 |
| Beginning Cash Position | 127,452 | 127,452 | 127,452 | 127,452 | 29,369 |
| End Cash Position | 86,863 | 110,444 | 87,175 | 114,839 | 127,452 |
| Net Cash Flow | $-40,589 | $-17,008 | $-40,277 | $-12,613 | $98,083 |
| Free Cash Flow | |||||
| Operating Cash Flow | -83,233 | -59,552 | -41,953 | -12,948 | -46,124 |
| Capital Expenditure | -67 | -48 | -28 | -10 | -146 |
| Free Cash Flow | -83,300 | -59,600 | -41,981 | -12,958 | -46,270 |